Publication: Cost of illness in patients with Duchenne muscular dystrophy in Portugal: The COIDUCH study
This article, published in PharmacoEconomics, provides results from an investigation to determine the cost of illness of Duchenne muscular dystrophy (DMD)
- Learn about the methods used to undertake a cross-sectional study of patients with DMD in Portugal, to evaluate the cost of illness
- Review the domains used to determine the societal cost of disease – including medical costs, informal care costs, and work-related costs
- Understand the total estimated costs of care for 46 patients, shown by age and ambulatory status
Thank you!
Already registered?
Register now to access the content on this page
Already registered?
If not, register below
You are now leaving MEDhub, a website provided by PTC Therapeutics. This link will take you to a website to which our Privacy Statement and our Terms and Conditions do not apply.
We encourage you to read the Privacy Policy and the Terms and Conditions of every website you visit. PTC Therapeutics does not endorse and/or influence the content found on websites not owned/operated by PTC Therapeutics.
MED-ALL-CORP-2200029 | June 2025
COMING SOON
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.